NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 107 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,436 | -58.7% | 4,146 | 0.0% | 0.00% | – |
| Q2 2023 | $10,738 | -70.6% | 4,146 | -53.7% | 0.00% | -100.0% |
| Q1 2023 | $36,569 | -18.7% | 8,963 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $44,994 | -57.1% | 8,963 | +11.9% | 0.00% | -50.0% |
| Q3 2022 | $105,000 | +69.4% | 8,012 | +66.3% | 0.00% | +100.0% |
| Q2 2022 | $62,000 | +100.0% | 4,817 | +138.8% | 0.00% | – |
| Q1 2022 | $31,000 | -26.2% | 2,017 | +0.8% | 0.00% | -100.0% |
| Q3 2021 | $42,000 | +7.7% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $39,000 | -100.0% | 2,000 | -50.0% | 0.00% | 0.0% |
| Q1 2021 | $116,280,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $232,513,000 | 49.48% |
| Ponoi II Management, LLC | 1,298,908 | $16,652,000 | 45.25% |
| Ponoi Management, LLC | 1,298,908 | $16,652,000 | 26.29% |
| Euclidean Capital LLC | 746,674 | $9,572,000 | 8.14% |
| StepStone Group LP | 1,573,357 | $20,170,000 | 2.16% |
| First Light Asset Management, LLC | 1,135,884 | $14,562,000 | 1.69% |
| Lexington Partners L.P. | 110,428 | $1,416,000 | 0.73% |
| Rubric Capital Management LP | 797,588 | $10,225,000 | 0.54% |
| Boxer Capital, LLC | 500,000 | $6,410,000 | 0.41% |
| DAFNA Capital Management LLC | 107,653 | $1,380,000 | 0.38% |